miRNA expression profiles in myelodysplastic syndromes reveal Epstein–Barr virus miR-BART13 dysregulation

References

• Platzbecker M, Meredyth-Stewart M, Ehninger G. The pathogenesis of myelodysplastic syndromes (MDS). Cancer Treat Rev 2007;33:S53–S58.
   Web of Science ®Google Scholar
• Bejar R, Ebert BL. The genetic basis of myelodysplastic syndromes. Hematol Oncol Clin North Am 2010;24:295–315.
   PubMed Web of Science ®Google Scholar
• Borze I, Juvonen E, Ninomiya S, Jee KJ, Elonen E, Knuutila S. High-resolution oligonucleotide array comparative genomic hybridization study and methylation status of the RPS14 gene in de novo myelodysplastic syndromes. Cancer Genet Cytogenet 2010;197:166–173.
   PubMed Web of Science ®Google Scholar
• Paulsson K, Heidenblad M, Strombeck B, et al. High-resolution genome-wide array-based comparative genome hybridization reveals cryptic chromosome changes in AML and MDS cases with trisomy 8 as the sole cytogenetic aberration. Leukemia 2006;20:840–846.
   PubMed Web of Science ®Google Scholar
• Martinez-Ramirez A, Urioste M, Melchor L, et al. Analysis of myelodysplastic syndromes with complex karyotypes by high-resolution comparative genomic hybridization and subtelomeric CGH array. Genes Chromosomes Cancer 2005;42:287–298.
   PubMed Web of Science ®Google Scholar
• Vercauteren SM, Sung S, Starczynowski DT, et al. Array comparative genomic hybridization of peripheral blood granulocytes of patients with myelodysplastic syndrome detects karyotypic abnormalities. Am J Clin Pathol 2010;134:119–126.
   PubMed Web of Science ®Google Scholar
• Langemeijer SM, Kuiper RP, Berends M, et al. Acquired mutations in TET2 are common in myelodysplastic syndromes. Nat Genet 2009;41:838–842.
   PubMed Web of Science ®Google Scholar
• Szpurka H, Jankowska AM, Makishima H, et al. Spectrum of mutations in RARS-T patients includes TET2 and ASXL1 mutations. Leuk Res 2010;34:969–973.
   PubMed Web of Science ®Google Scholar
• Heinrichs S, Kulkarni RV, Bueso-Ramos CE, et al. Accurate detection of uniparental disomy and microdeletions by SNP array analysis in myelodysplastic syndromes with normal cytogenetics. Leukemia 2009;23:1605–1613.
   PubMed Web of Science ®Google Scholar
• Mohamedali A, Gaken J, Twine NA, et al. Prevalence and prognostic significance of allelic imbalance by single-nucleotide polymorphism analysis in low-risk myelodysplastic syndromes. Blood 2007;110:3365–3373.
   PubMed Web of Science ®Google Scholar
• Dutta KK, Zhong Y, Liu YT, et al. Association of microRNA-34a overexpression with proliferation is cell type-dependent. Cancer Sci 2007;98:1845–1852.
   PubMed Web of Science ®Google Scholar
• Raponi M, Dossey L, Jatkoe T, et al. MicroRNA classifiers for predicting prognosis of squamous cell lung cancer. Cancer Res 2009;69:5776–5783.
   PubMed Web of Science ®Google Scholar
• Costa A, Osorio C, Dias S. MicroRNA expression profiling in bone marrow: implications in hematological malignancies. Biotechnol J 2009;4:88–97.
   PubMedGoogle Scholar
• Dickstein J, Senyuk V, Premanand K, et al. Methylation and silencing of miRNA-124 by EVI1 and self-renewal exhaustion of hematopoietic stem cells in murine myelodysplastic syndrome. Proc Natl Acad Sci USA 2010;107:9783–9788.
   PubMed Web of Science ®Google Scholar
• Kumar M, Narla A, Nonami A, et al. Coordinate loss of a microRNA mir 145 and a protein-coding gene RPS14 cooperate in the pathogenesis of 5q- syndrome. Blood 2009;114(Suppl. 1): Abstract 947.
   Google Scholar
• Gaken J, Mohamedali AZ, Twine N, et al. MicroRNA expression profiling of high and low risk MDS. Blood 2008;112(Suppl. 1): Abstract 3645.
   Google Scholar
• Dostalova Merkerova M, Krejcik Z, Votavova H, Belickova M, Vasikova A, Cermak J. Distinctive microRNA expression profiles in CD34+ bone marrow cells from patients with myelodysplastic syndrome. Eur J Hum Genet 2011;19:313–319.
   PubMed Web of Science ®Google Scholar
• Jaffe ES, Harris NL, Stein H, Vardiman JW. WHO classification of tumours: pathology and genetics of tumours of haematopoietic and lymphoid tissues. Lyon: IARC; 2001. pp 61–73.
   Google Scholar
• Borze I, Guled M, Musse S, et al. MicroRNA microarrays on archive bone marrow core biopsies of leukemias–method validation. Leuk Res 2011;35:188–195.
   PubMed Web of Science ®Google Scholar
• R Development Core Team. R: a language and environment for statistical computing. Vienna: R Foundation for Statistical Computing; 2009.
   Google Scholar
• Gentleman RC, Carey VJ, Bates DM, et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 2004;5:R80.
   PubMed Web of Science ®Google Scholar
• Lopez-Romero P, Gonzalez MA, Callejas S, Dopazo A, Irizarry RA. Processing of agilent microRNA array data. BMC Res Notes 2010;3:18.
   PubMedGoogle Scholar
• Irizarry RA, Hobbs B, Collin F, et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 2003;4:249–264.
   PubMed Web of Science ®Google Scholar
• Smyth GK, Speed T. Normalization of cDNA microarray data. Methods 2003;31:265–273.
   PubMed Web of Science ®Google Scholar
• Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc B 1995;57:289–300.
   Google Scholar
• Krek A, Grun D, Poy MN, et al. Combinatorial microRNA target predictions. Nat Genet 2005;37:495–500. [Available from: http://pictar.mdc-berlin.de/]
   PubMed Web of Science ®Google Scholar
• Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005;120:15–20. [Available from: http://targetscan.org/]
   PubMed Web of Science ®Google Scholar
• Ritchie ME, Silver J, Oshlack A, et al. A comparison of background correction methods for two-colour microarrays. Bioinformatics 2007;23:2700–2707.
   PubMed Web of Science ®Google Scholar
• van de Wiel MA, Brosens R, Eilers PH, et al. Smoothing waves in array CGH tumor profiles. Bioinformatics 2009;25:1099–1104.
   PubMed Web of Science ®Google Scholar
• Siggberg L, Ala-Mello S, Jaakkola E, et al. Array CGH in molecular diagnosis of mental retardation - a study of 150 Finnish patients. Am J Med Genet A 2010;152A:1398–1410.
   PubMed Web of Science ®Google Scholar
• Venkatraman ES, Olshen AB. A faster circular binary segmentation algorithm for the analysis of array CGH data. Bioinformatics 2007;23:657–663.
   PubMed Web of Science ®Google Scholar
• van de Wiel MA, Kim KI, Vosse SJ, van Wieringen WN, Wilting SM, Ylstra B. CGHcall: calling aberrations for array CGH tumor profiles. Bioinformatics 2007;23:892–894.
   PubMed Web of Science ®Google Scholar
• Scheinin I, Myllykangas S, Borze I, Bohling T, Knuutila S, Saharinen J. CanGEM: mining gene copy number changes in cancer. Nucleic Acids Res 2008;36:D830–D835.
   PubMed Web of Science ®Google Scholar
• Hussein K, Theophile K, Busche G, et al. Aberrant microRNA expression pattern in myelodysplastic bone marrow cells. Leuk Res 2010;34:1169–1174.
   PubMed Web of Science ®Google Scholar
• Hussein K, Theophile K, Busche G, et al. Significant inverse correlation of microRNA-150/MYB and microRNA-222/p27 in myelodysplastic syndrome. Leuk Res 2010;34:328–334.
   PubMed Web of Science ®Google Scholar
• Pons A, Nomdedeu B, Navarro A, et al. Hematopoiesis-related microRNA expression in myelodysplastic syndromes. Leuk Lymphoma 2009;50:1854–1859.
   PubMed Web of Science ®Google Scholar
• Starczynowski DT, Kuchenbauer F, Argiropoulos B, et al. Identification of miR-145 and miR-146a as mediators of the 5q- syndrome phenotype. Nat Med 2010;16:49–58.
   PubMed Web of Science ®Google Scholar
• Bousquet M, Quelen C, Rosati R, et al. Myeloid cell differentiation arrest by miR-125b-1 in myelodysplastic syndrome and acute myeloid leukemia with the t(2;11)(p21;q23) translocation. J Exp Med 2008;205:2499–506.
   PubMed Web of Science ®Google Scholar
• Hermeking H. The miR-34 family in cancer and apoptosis. Cell Death Differ 2010;17:193–199.
   PubMed Web of Science ®Google Scholar
• Cazzola M. Myelodysplastic syndrome with isolated 5q deletion (5q- syndrome). A clonal stem cell disorder characterized by defective ribosome biogenesis. Haematologica 2008;93:967–972.
   PubMed Web of Science ®Google Scholar
• Seto E, Moosmann A, Gromminger S, Walz N, Grundhoff A, Hammerschmidt W. Micro RNAs of Epstein-Barr virus promote cell cycle progression and prevent apoptosis of primary human B cells. PLoS Pathog 2010;6:pii:e1001063.
   Web of Science ®Google Scholar
• Pfeffer S, Voinnet O. Viruses, microRNAs and cancer. Oncogene 2006;25:6211–62119.
   PubMed Web of Science ®Google Scholar
• Raza A. Myelodysplastic syndromes may have an infectious etiology. J Toxicol Environ Health A 2000;61:387–390.
   PubMed Web of Science ®Google Scholar
• Raza A. Hypothesis: myelodysplastic syndromes may have a viral etiology. Int J Hematol 1998;68:245–256.
   PubMed Web of Science ®Google Scholar
• Selcuklu SD, Donoghue MT, Spillane C. miR-21 as a key regulator of oncogenic processes. Biochem Soc Trans 2009;37:918–925.
   PubMed Web of Science ®Google Scholar
• Kerbauy DB, Deeg HJ. Apoptosis and antiapoptotic mechanisms in the progression of myelodysplastic syndrome. Exp Hematol 2007;35:1739–1746.
   PubMed Web of Science ®Google Scholar
• Swerdlow SH, Campo E, Harris NL, et al. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Lyon: IARC; 2008.
   Google Scholar